Home » Newsletters » BioWorld Science

BioWorld Science

June 7, 2022

View Archived Issues

LIPA targeting with ERX-41 shown useful to treat TNBC

Genentech describes von Hippel-Lindau disease tumor suppressor inhibitors

New cytokine inhibitors patented by Peptinov SAS, Conservatoire National des Arts et Metiers

New HSD17B13 inhibitors discovered at Inipharm

Neuron23 divulges LRRK2/NUAK1/TYK2 inhibitors

New Bruton tyrosine kinase inhibitors identified at Biogen

TPI1 as a novel therapeutic target in breast cancer

Heme oxygenase-1-modified exosomes developed for temozolomide-resistant glioblastoma

Molecule "superglues" itself to enzyme to fight all stages of malaria parasite

Novel fungal Hsp90 inhibitors for the treatment of azole-resistant candidiasis

BioVaxys reports progress in pan-sarbecovirus vaccine program

Analysis of pain insensitivity disorder reveals new target for pain relief

Karolinska Development invests in PharmNovo to advance neuropathic pain treatment

Genuv and Nanocarry partner to treat metastatic tumors in the brain

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...